Inovio Pharmaceuticals Inc (INO) — Capital Reinvestment Ratio

Latest as of September 2015: 0.05x

Inovio Pharmaceuticals Inc (INO) has a Capital Reinvestment Ratio of 0.05x as of September 2015, meaning it reinvests 0% of its operating cash flow ($15.42 Million) in capital expenditures ($782.60K). See Inovio Pharmaceuticals Inc net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.05x

Capex / Operating Cash Flow

Operating Cash Flow

$15.42 Million

USD

Capital Expenditures

$782.60K

USD

Data as of

Sep 2015

Most recent filing

Annual Capital Reinvestment Ratio for Inovio Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Inovio Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see market value of Inovio Pharmaceuticals Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow